While direct in vivo models of leptin-mediated autoimmune antibody production are limited, clinical evidence shows elevated leptin levels in human autoimmune diseases such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and MS [186]. This evidence concerns the gene LEP and systemic lupus erythematosus.